C. J. Saavedra et al. / Tetrahedron Letters 47 (2006) 8757–8760
8759
References and notes
1
. For recent reviews on the synthesis or uses of b-amino
acids, see: (a) Liljeblad, A.; Kanerva, L. T. Tetrahedron
2
006, 62, 5831–5854; (b) Enantioselective Synthesis of b-
amino Acids; Juaristi, E., Soloshonok, V. A., Eds.; Wiley-
VCH: New York, 2005; (c) Viso, A.; Fern a´ ndez de la
Pradilla, R.; Garc ´ı a, A.; Flores, A. Chem. Rev. 2005, 105,
3167–3196; (d) Xu, L.-W.; Xia, C.-G. Eur. J. Org. Chem.
2005, 633–639; (e) Cordova, A. Acc. Chem. Res. 2004, 37,
102–112; (f) Davies, S. G.; Smith, A. D.; Price, P. D.
Tetrahedron: Asymmetry 2005, 16, 2833–2891; (g) France,
S.; Weatherwax, A.; Taggi, A. E.; Lectka, T. Acc. Chem.
Res. 2004, 37, 592–600; (h) Ma, J.-A. Angew. Chem., Int.
Ed. 2003, 42, 4290–4299; (i) Taggi, A. E.; Hafez, A. M.;
Lectka, T. Acc. Chem. Res. 2003, 36, 10–19; (j) Sewald, N.
Angew. Chem., Int. Ed. 2003, 42, 5794–5795; (k) Liu, M.;
Sibi, M. P. Tetrahedron 2002, 58, 7991–8035; (l) Ellman, J.
A.; Owens, T. D.; Tang, T. P. Acc. Chem. Res. 2002, 35,
Scheme 3. Reagents and conditions: (i) DIB, I
2 2 2
, hm, CH Cl , then 0 ꢂC,
BF ÆOEt , Me C@C(OTMS)OMe, 58%, 24:25 5:2.
3
2
2
984–995; (m) Park, K.-H.; Kurth, M. J. Tetrahedron 2002,
58, 8629–8659; (n) F u¨ lop, F. Chem. Rev. 2001, 101, 2181–
2204.
2
. (a) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173–180; (b)
Abele, S.; Seebach, D. Eur. J. Org. Chem. 2000, 1–15; (c)
Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev.
2
001, 101, 3219–3232; (d) Bauvois, B.; Dauzonne, D. Med.
Res. Rev. 2006, 26, 88–130.
3
4
5
. Matsumura, Y.; Kanda, Y.; Shirai, K.; Onomura, O.;
Maki, T. Tetrahedron 2000, 56, 7411–7422, and references
cited therein.
. (a) Pearson, W. H.; Hines, J. V. J. Org. Chem. 1989, 54,
4
235–4237; (b) Suda, H.; Takita, T.; Aoyagi, T.; Umez-
awa, H. J. Antibiot. 1976, 29, 600–601.
. For examples on the decarboxylation of amino acids, see:
(
a) Boto, A.; Gallardo, J. A.; Hern a´ ndez, R.; Saavedra, C.
J. Tetrahedron Lett. 2005, 46, 7807–7811; (b) Boto, A.; de
Le o´ n, Y.; Gallardo, J. A.; Hern a´ ndez, R. Eur. J. Org.
Chem. 2005, 3461–3468; (c) Boto, A.; Hern a´ ndez, R.;
Su a´ rez, E. J. Org. Chem. 2000, 64, 4930–4937.
Figure 2. X-ray analysis of dipeptide 24.
6
. For reviews on b-scission, see: (a) Hartung, J.; Gottwald,
T.; Spehar, K. Synthesis 2002, 1469–1498; (b) Zhdankin,
V.; Stang, P. J. Chem. Rev. 2002, 102, 2523–2584; (c)
Togo, H.; Katohgi, M. Synlett 2001, 565–581; (d) Su a´ rez,
E.; Rodr ´ı guez, M. S. In Radicals in Organic Synthesis;
Renaud, P., Sibi, M. P., Eds.; Wiley-VCH: Weinheim,
2001; Vol. 2, pp 440–454; For recent references on the b-
fragmentation reaction, see: (e) Boto, A.; Hern a´ ndez, D.;
Hern a´ ndez, R.; Su a´ rez, E. J. Org. Chem. 2003, 68, 5310–
The reaction was studied with the Leu-Ala derivative
3, using Me C@C(OTMS)OMe as the nucleophile.
2
2
The scission–alkylation afforded modified dipeptides
1
4
2
4
and 25 (Scheme 3), which could be separated by
chromatography and crystallization. The configuration
1
5
of 24 was determined by X-ray analysis (Fig. 2). As
expected, the reaction was diastereoselective (24:25,
5
:2). However, the isolation of the two possible diaste-
5
319.
reomers is also interesting, in order to determine the
influence of the configuration into the biological activity.
7
. For a discussion on the mechanism of the oxidation step,
see: Boto, A.; Hern a´ ndez, R.; Le o´ n, Y.; Murgu ´ı a, J. R.;
Rodr ´ı guez-Afonso, A. Eur. J. Org. Chem. 2005, 673–
In summary, the one-pot fragmentation–alkylation reac-
tion is a versatile and efficient pathway to obtain many
different b-amino acid derivatives from readily available
precursors. The synthesis of modified peptides is another
interesting application of this reaction.
6
82.
8
. For recent reviews on acyliminium ions, see: (a) Marya-
noff, B. E.; Zhang, H.-C.; Cohen, J. H.; Turchi, I. J.;
Maryanoff, C. A. Chem. Rev. 2004, 104, 1431–1628; (b)
Royer, J.; Bonin, M.; Micouin, L. Chem. Rev. 2004, 104,
2
311–2352.
9
. (a) Kubryk, M.; Hansen, K.-B. Tetrahedron: Asymmetry
2
4
006, 17, 205–209; (b) Weber, A. J. Med. Chem. 2004, 48,
135–4141.
Acknowledgements
1
1
0. Wolin, R. L.; Santill a´ n, A., Jr.; Barclay, T.; Tang, L.;
Venkatesan, H.; Wilson, S.; Lee, D. H.; Lovenberg, T. W.
Bioorg. Med. Chem. 2004, 12, 4493–4509.
1. Boto, A.; Hern a´ ndez, R.; Le o´ n, Y.; Su a´ rez, E. J. Org.
Chem. 2001, 66, 7796–7803.
12. (a) La Ferla, B.; Bugada, P.; Cipolla, L.; Peri, F.; Nicotra,
F. Eur. J. Org. Chem. 2004, 2451–2470; (b) Schweizer, F.
Angew. Chem., Int. Ed. 2002, 41, 230–253.
This work was supported by the Research Programme
PPQ2003-01379 of the Plan Nacional de Investigaci o´ n
Cient ´ı fica, Desarrollo e Innovaci o´ n Tecnol o´ gica, Minis-
terios de Ciencia y Tecnolog ´ı a y de Educaci o´ n y Ciencia,
Spain. We also acknowledge financial support from
FEDER funds. C.J.S. thanks the CSIC for an I3P
fellowship.